Multiple sclerosis (MS). Demyelinating diseases of the central nervous system
Conditions
Interventions
Intervention 1: Intervention group: Every 12 hours after meals, they received a capsule containing Centella asiatica plant powder for two months. Intervention 2: Control group: Every 12 hours after me
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Multiple sclerosis patients with complaints of cognitive impairment referred to the MS clinic and had proven cognitive impairment based on the BICAMS (brief international cognitive assessment for MS) test.
Exclusion criteria
Exclusion criteria: Suffering from psychiatric diseases such as severe depression, schizophrenia, etc. pregnancy breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of cognitive impairment. Timepoint: Investigation of cognitive impairment at the beginning of the study (before the start of the intervention) and two months after the start of the intervention with the Centella asiatica. Method of measurement: BICAMS questionnaire.;Quality of Life. Timepoint: At the beginning of the study (before the start of the intervention) and two months after the start of Centella Asiatica. Method of measurement: MSQOL54 questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Possible side effects. Timepoint: At the end of the study. Method of measurement: Registration by the patient and questions from the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohadese Kamali
Kerman University of Medical Sciences
Outcome results
None listed